STANCHART (02888) plans to issue $1 billion fixed rate reset perpetual callable convertible securities.
Standard Chartered Group (02888) announced that the company plans to issue a total of $1 billion worth of ... on November 14, 2025.
STANCHART (02888) announced that the company plans to issue a total of 1 billion US dollars of fixed rate resettable perpetual subordinated convertible securities on November 14, 2025 (ISIN restricted global certificate: US853254DH03, ISIN unrestricted global certificate: USG84228HA94).
The company will apply for the securities to be listed on the International Securities Market of the London Stock Exchange for trading. The company will also apply to the Hong Kong Stock Exchange for approval for the listing and trading of any ordinary shares issued after the conversion of the securities. The face value of the securities is 200,000 US dollars, with any excess amount to be calculated in multiples of 1,000 US dollars.
Related Articles

HK Stock Market Move | LEADS BIOLABS-B(09887) has increased by over 3%, and 5 research results in the field of blood tumors will be announced at the 2025 ASH Annual Meeting.

Green financial construction of BANK OF GANSURooting in the Loess Plateau's New Ecological System, Progressing towards a Green Future.

The technology giant IBM follows the trend of "AI boosting efficiency": laying off thousands of employees, accelerating its transformation towards software business.
HK Stock Market Move | LEADS BIOLABS-B(09887) has increased by over 3%, and 5 research results in the field of blood tumors will be announced at the 2025 ASH Annual Meeting.

Green financial construction of BANK OF GANSURooting in the Loess Plateau's New Ecological System, Progressing towards a Green Future.

The technology giant IBM follows the trend of "AI boosting efficiency": laying off thousands of employees, accelerating its transformation towards software business.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


